Log In
Print
BCIQ
Print
Print this Print this
 

linagliptin/metformin (Jentadueto)

  Manage Alerts
Collapse Summary General Information
Company Boehringer Ingelheim GmbH
DescriptionCombination of Tradjenta linagliptin, a xanthine-based dipeptidyl peptidase-4 (DPP-4) inhibitor, and metformin
Molecular Target Dipeptidyl peptidase-4 (DPP-4) (CD26)
Mechanism of ActionDipeptidyl peptidase-4 (DPP-4) inhibitor
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentMarketed
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation

Partner

Eli Lilly and Co.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today